These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12951863)

  • 21. The synergistic efficacy of adalimumab and pamidronate in a patient with ankylosing spondylitis.
    Slobodin G; Rosner I; Rimar D; Boulman N; Rozenbaum M; Odeh M
    Clin Rheumatol; 2010 Jul; 29(7):793-4. PubMed ID: 20111975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
    Gorman JD; Sack KE; Davis JC
    N Engl J Med; 2002 May; 346(18):1349-56. PubMed ID: 11986408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of recurrent oral aphthous ulcers with etanercept.
    Scheinberg MA
    Clin Exp Rheumatol; 2002; 20(5):733-4. PubMed ID: 12412213
    [No Abstract]   [Full Text] [Related]  

  • 24. Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidance.
    Wailoo A; Bansback N; Chilcott J
    Rheumatology (Oxford); 2008 Feb; 47(2):119-20. PubMed ID: 18208819
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of etanercept on iritis in patients with ankylosing spondylitis.
    Rosenbaum JT
    Arthritis Rheum; 2004 Nov; 50(11):3736-7. PubMed ID: 15529379
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of ankylosing spondylitis with pamidronate: an open label study.
    Grover R; Shankar S; Aneja R; Marwaha V; Gupta R; Kumar A
    Ann Rheum Dis; 2006 May; 65(5):688-9. PubMed ID: 16611869
    [No Abstract]   [Full Text] [Related]  

  • 27. Etanercept: in ankylosing spondylitis.
    McCormack PL; Wellington K
    BioDrugs; 2004; 18(3):199-205; discussion 206. PubMed ID: 15161337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-Hodgkin's lymphoma following treatment with etanercept in ankylosing spondylitis.
    Aksu K; Cagirgan S; Ozsan N; Keser G; Sahin F
    Rheumatol Int; 2011 Dec; 31(12):1645-7. PubMed ID: 20013270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical research for curing ankylosing spondylitis through combining etanercept, thalidomide and sulfasalazine.
    Xiao P; Pang C; Zhu X; Wu X
    Pak J Pharm Sci; 2015 Jan; 28(1 Suppl):359-62. PubMed ID: 25631513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial.
    Braun J; van der Horst-Bruinsma IE; Huang F; Burgos-Vargas R; Vlahos B; Koenig AS; Freundlich B
    Arthritis Rheum; 2011 Jun; 63(6):1543-51. PubMed ID: 21630245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis.
    Toussirot E; Wendling D
    Curr Opin Rheumatol; 2007 Jul; 19(4):340-5. PubMed ID: 17551363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk: benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis.
    Fleischmann R; Iqbal I
    Drugs Aging; 2007; 24(3):239-54. PubMed ID: 17362051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hodgkin's lymphoma following treatment with etanercept in ankylosing spondylitis.
    Aksu K; Donmez A; Ertan Y; Keser G; Inal V; Oder G; Tombuloglu M; Kabasakal Y; Doganavsargil E
    Rheumatol Int; 2007 Dec; 28(2):185-7. PubMed ID: 17622534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents.
    Seyahi E; Ozdogan H; Celik S; Ugurlu S; Yazici H
    Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S99-103. PubMed ID: 17067437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Response to anti-TNF-alpha treatment for secondary renal amyloidosis in a patient with ankylosing spondylitis].
    Bellissimo S; Ferrucci MG; Gallo A; Stisi S
    Reumatismo; 2007; 59(3):240-3. PubMed ID: 17898885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease-modifying effect of etanercept versus sulphasalazine on spinal mobility in patients with ankylosing spondylitis.
    Hendrix S; Koenig A; Li W; Singh A
    J Int Med Res; 2013 Oct; 41(5):1606-11. PubMed ID: 23975857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biological treatment of ankylosing spondylitis].
    Freiesleben S; Schou M
    Ugeskr Laeger; 2008 Jun; 170(24):2140-5. PubMed ID: 18565298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biologic therapies in the spondyloarthritis: new opportunities, new challenges.
    Braun J; Brandt J; Listing J; Rudwaleit M; Sieper J
    Curr Opin Rheumatol; 2003 Jul; 15(4):394-407. PubMed ID: 12819466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-TNF-alpha treatment and spondyloarthropathies].
    Braun Y; Balbir-Gurman A
    Harefuah; 2002 Nov; 141(11):965-8, 1010. PubMed ID: 12476631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical study of etanercept for treating ankylosing spondylitis].
    Liang LQ; Zhan ZP; Ye YJ; Fu D; Xu HS; Yang XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1349-51. PubMed ID: 18753057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.